nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—RYR1—kidney cancer	0.279	0.61	CbGaD
Caffeine—PIK3CA—kidney cancer	0.133	0.292	CbGaD
Caffeine—CYP1A1—kidney cancer	0.0293	0.0641	CbGaD
Caffeine—CYP1B1—Erlotinib—kidney cancer	0.0203	0.0642	CbGbCtD
Caffeine—CYP3A7—Temsirolimus—kidney cancer	0.019	0.0602	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.019	0.0602	CbGbCtD
Caffeine—CYP1B1—Paclitaxel—kidney cancer	0.0186	0.0588	CbGbCtD
Caffeine—ABCB1—kidney cancer	0.0155	0.034	CbGaD
Caffeine—CYP3A5—Temsirolimus—kidney cancer	0.0142	0.0451	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—kidney cancer	0.01	0.0317	CbGbCtD
Caffeine—ABCB1—Temsirolimus—kidney cancer	0.00927	0.0294	CbGbCtD
Caffeine—CYP1A1—Erlotinib—kidney cancer	0.00889	0.0282	CbGbCtD
Caffeine—CYP2D6—Temsirolimus—kidney cancer	0.00873	0.0277	CbGbCtD
Caffeine—CYP3A4—Everolimus—kidney cancer	0.00822	0.0261	CbGbCtD
Caffeine—CYP2C8—Pazopanib—kidney cancer	0.00719	0.0228	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00651	0.0206	CbGbCtD
Caffeine—CYP3A7—Paclitaxel—kidney cancer	0.00651	0.0206	CbGbCtD
Caffeine—CYP3A7—Sorafenib—kidney cancer	0.00579	0.0183	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00579	0.0183	CbGbCtD
Caffeine—CYP3A7—Vincristine—kidney cancer	0.00562	0.0178	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00562	0.0178	CbGbCtD
Caffeine—CYP1A2—Pazopanib—kidney cancer	0.00557	0.0176	CbGbCtD
Caffeine—CYP3A4—Temsirolimus—kidney cancer	0.00555	0.0176	CbGbCtD
Caffeine—CYP3A5—Erlotinib—kidney cancer	0.00534	0.0169	CbGbCtD
Caffeine—CYP2C9—Capecitabine—kidney cancer	0.00523	0.0166	CbGbCtD
Caffeine—CYP2C8—Erlotinib—kidney cancer	0.00513	0.0163	CbGbCtD
Caffeine—PIK3CA—nephron—kidney cancer	0.00504	0.127	CbGeAlD
Caffeine—CYP3A5—Paclitaxel—kidney cancer	0.00489	0.0155	CbGbCtD
Caffeine—ABCB1—Pazopanib—kidney cancer	0.00487	0.0154	CbGbCtD
Caffeine—CYP2C8—Paclitaxel—kidney cancer	0.0047	0.0149	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00469	0.0149	CbGbCtD
Caffeine—CYP3A7—Sunitinib—kidney cancer	0.00469	0.0149	CbGbCtD
Caffeine—CYP2D6—Pazopanib—kidney cancer	0.00459	0.0145	CbGbCtD
Caffeine—ABCB1—Dactinomycin—kidney cancer	0.00445	0.0141	CbGbCtD
Caffeine—CYP3A5—Sorafenib—kidney cancer	0.00434	0.0138	CbGbCtD
Caffeine—CYP3A5—Vincristine—kidney cancer	0.00421	0.0134	CbGbCtD
Caffeine—CYP2C8—Sorafenib—kidney cancer	0.00417	0.0132	CbGbCtD
Caffeine—CYP1A2—Erlotinib—kidney cancer	0.00397	0.0126	CbGbCtD
Caffeine—ABCB1—Gemcitabine—kidney cancer	0.00352	0.0112	CbGbCtD
Caffeine—CYP3A5—Sunitinib—kidney cancer	0.00352	0.0111	CbGbCtD
Caffeine—ABCB1—Erlotinib—kidney cancer	0.00347	0.011	CbGbCtD
Caffeine—CYP2C9—Paclitaxel—kidney cancer	0.00328	0.0104	CbGbCtD
Caffeine—CYP2D6—Erlotinib—kidney cancer	0.00327	0.0104	CbGbCtD
Caffeine—CYP1A2—Sorafenib—kidney cancer	0.00323	0.0102	CbGbCtD
Caffeine—ABCB1—Paclitaxel—kidney cancer	0.00318	0.0101	CbGbCtD
Caffeine—CYP3A4—Pazopanib—kidney cancer	0.00292	0.00925	CbGbCtD
Caffeine—CYP2C9—Sorafenib—kidney cancer	0.00291	0.00923	CbGbCtD
Caffeine—ABCB1—Sorafenib—kidney cancer	0.00283	0.00895	CbGbCtD
Caffeine—ABCB1—Vinblastine—kidney cancer	0.00279	0.00884	CbGbCtD
Caffeine—ABCB1—Vincristine—kidney cancer	0.00274	0.00869	CbGbCtD
Caffeine—CYP2D6—Sorafenib—kidney cancer	0.00266	0.00844	CbGbCtD
Caffeine—CYP2D6—Vinblastine—kidney cancer	0.00263	0.00833	CbGbCtD
Caffeine—ABCB1—Sunitinib—kidney cancer	0.00229	0.00725	CbGbCtD
Caffeine—CYP3A4—Erlotinib—kidney cancer	0.00208	0.0066	CbGbCtD
Caffeine—CYP3A4—Paclitaxel—kidney cancer	0.00191	0.00604	CbGbCtD
Caffeine—ABCB1—Doxorubicin—kidney cancer	0.00171	0.00543	CbGbCtD
Caffeine—CYP3A4—Sorafenib—kidney cancer	0.00169	0.00536	CbGbCtD
Caffeine—CYP3A4—Vinblastine—kidney cancer	0.00167	0.0053	CbGbCtD
Caffeine—CYP3A4—Vincristine—kidney cancer	0.00164	0.00521	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—kidney cancer	0.00162	0.00512	CbGbCtD
Caffeine—CYP3A4—Sunitinib—kidney cancer	0.00137	0.00435	CbGbCtD
Caffeine—PRKDC—nephron tubule—kidney cancer	0.00134	0.0338	CbGeAlD
Caffeine—PRKDC—Vinblastine—Vincristine—kidney cancer	0.0013	1	CbGdCrCtD
Caffeine—ATM—renal system—kidney cancer	0.00129	0.0324	CbGeAlD
Caffeine—ATM—cardiac atrium—kidney cancer	0.00116	0.0291	CbGeAlD
Caffeine—PRKDC—cortex of kidney—kidney cancer	0.00115	0.0289	CbGeAlD
Caffeine—PIK3CD—renal system—kidney cancer	0.00114	0.0288	CbGeAlD
Caffeine—PIK3CD—kidney—kidney cancer	0.00111	0.0278	CbGeAlD
Caffeine—PIK3CB—nephron tubule—kidney cancer	0.0011	0.0276	CbGeAlD
Caffeine—PRKDC—cardiac atrium—kidney cancer	0.00109	0.0275	CbGeAlD
Caffeine—PIK3CA—nephron tubule—kidney cancer	0.00109	0.0273	CbGeAlD
Caffeine—CYP3A4—Doxorubicin—kidney cancer	0.00103	0.00325	CbGbCtD
Caffeine—PIK3CB—renal system—kidney cancer	0.000999	0.0251	CbGeAlD
Caffeine—PIK3CA—renal system—kidney cancer	0.000988	0.0248	CbGeAlD
Caffeine—CYP1A2—urine—kidney cancer	0.00097	0.0244	CbGeAlD
Caffeine—PIK3CB—kidney—kidney cancer	0.000965	0.0243	CbGeAlD
Caffeine—PIK3CA—kidney—kidney cancer	0.000955	0.024	CbGeAlD
Caffeine—PIK3CB—cortex of kidney—kidney cancer	0.00094	0.0236	CbGeAlD
Caffeine—PIK3CA—cortex of kidney—kidney cancer	0.00093	0.0234	CbGeAlD
Caffeine—CYP2C9—urine—kidney cancer	0.000921	0.0231	CbGeAlD
Caffeine—PIK3CB—gonad—kidney cancer	0.000895	0.0225	CbGeAlD
Caffeine—PIK3CB—cardiac atrium—kidney cancer	0.000894	0.0225	CbGeAlD
Caffeine—PIK3CA—gonad—kidney cancer	0.000886	0.0223	CbGeAlD
Caffeine—PIK3CA—cardiac atrium—kidney cancer	0.000885	0.0222	CbGeAlD
Caffeine—CYP2E1—urine—kidney cancer	0.000873	0.0219	CbGeAlD
Caffeine—CYP3A4—urine—kidney cancer	0.000702	0.0176	CbGeAlD
Caffeine—CYP2D6—urine—kidney cancer	0.000691	0.0174	CbGeAlD
Caffeine—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000608	0.0153	CbGeAlD
Caffeine—ADORA2A—gonad—kidney cancer	0.000543	0.0136	CbGeAlD
Caffeine—ADORA1—renal system—kidney cancer	0.000522	0.0131	CbGeAlD
Caffeine—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000521	0.0131	CbGeAlD
Caffeine—ADORA1—kidney—kidney cancer	0.000505	0.0127	CbGeAlD
Caffeine—ADORA1—cortex of kidney—kidney cancer	0.000492	0.0124	CbGeAlD
Caffeine—ADORA1—cardiac atrium—kidney cancer	0.000468	0.0118	CbGeAlD
Caffeine—CYP1B1—nephron tubule—kidney cancer	0.000364	0.00916	CbGeAlD
Caffeine—PDE4B—cortex of kidney—kidney cancer	0.000364	0.00914	CbGeAlD
Caffeine—Blood creatinine increased—Pazopanib—kidney cancer	0.000362	0.00433	CcSEcCtD
Caffeine—Dry skin—Pazopanib—kidney cancer	0.000354	0.00424	CcSEcCtD
Caffeine—Sepsis—Erlotinib—kidney cancer	0.000352	0.00421	CcSEcCtD
Caffeine—PDE4B—gonad—kidney cancer	0.000346	0.00871	CbGeAlD
Caffeine—PDE4B—cardiac atrium—kidney cancer	0.000346	0.0087	CbGeAlD
Caffeine—Deafness—Vinblastine—kidney cancer	0.000343	0.0041	CcSEcCtD
Caffeine—CYP1B1—renal system—kidney cancer	0.000331	0.00832	CbGeAlD
Caffeine—CYP1B1—kidney—kidney cancer	0.00032	0.00805	CbGeAlD
Caffeine—Hyperglycaemia—Temsirolimus—kidney cancer	0.00032	0.00383	CcSEcCtD
Caffeine—Infestation—Temsirolimus—kidney cancer	0.000316	0.00378	CcSEcCtD
Caffeine—Infestation NOS—Temsirolimus—kidney cancer	0.000316	0.00378	CcSEcCtD
Caffeine—Hypoglycaemia—Everolimus—kidney cancer	0.000313	0.00374	CcSEcCtD
Caffeine—Pulmonary oedema—Sunitinib—kidney cancer	0.000313	0.00374	CcSEcCtD
Caffeine—CYP1B1—cortex of kidney—kidney cancer	0.000312	0.00784	CbGeAlD
Caffeine—Renal failure—Temsirolimus—kidney cancer	0.000311	0.00372	CcSEcCtD
Caffeine—Sepsis—Sunitinib—kidney cancer	0.000305	0.00365	CcSEcCtD
Caffeine—Infestation NOS—Pazopanib—kidney cancer	0.000298	0.00356	CcSEcCtD
Caffeine—Infestation—Pazopanib—kidney cancer	0.000298	0.00356	CcSEcCtD
Caffeine—CYP1B1—gonad—kidney cancer	0.000297	0.00746	CbGeAlD
Caffeine—Creatinine increased—Gemcitabine—kidney cancer	0.000296	0.00354	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Erlotinib—kidney cancer	0.000295	0.00352	CcSEcCtD
Caffeine—Irritability—Everolimus—kidney cancer	0.000291	0.00349	CcSEcCtD
Caffeine—Sepsis—Dactinomycin—kidney cancer	0.000289	0.00345	CcSEcCtD
Caffeine—Blood creatinine increased—Everolimus—kidney cancer	0.000286	0.00342	CcSEcCtD
Caffeine—Haemoglobin decreased—Capecitabine—kidney cancer	0.000281	0.00337	CcSEcCtD
Caffeine—Dry skin—Everolimus—kidney cancer	0.00028	0.00335	CcSEcCtD
Caffeine—Hypercalcaemia—Capecitabine—kidney cancer	0.000279	0.00333	CcSEcCtD
Caffeine—Gastritis—Everolimus—kidney cancer	0.00027	0.00323	CcSEcCtD
Caffeine—Dry skin—Erlotinib—kidney cancer	0.00027	0.00323	CcSEcCtD
Caffeine—Haemoglobin—Pazopanib—kidney cancer	0.000269	0.00322	CcSEcCtD
Caffeine—Urine output increased—Vincristine—kidney cancer	0.000269	0.00321	CcSEcCtD
Caffeine—Haemorrhage—Pazopanib—kidney cancer	0.000267	0.0032	CcSEcCtD
Caffeine—Accidental injury—Paclitaxel—kidney cancer	0.000267	0.00319	CcSEcCtD
Caffeine—Cardiac disorder—Temsirolimus—kidney cancer	0.000263	0.00315	CcSEcCtD
Caffeine—Hypoglycaemia—Sunitinib—kidney cancer	0.000261	0.00313	CcSEcCtD
Caffeine—Gastritis—Erlotinib—kidney cancer	0.000261	0.00312	CcSEcCtD
Caffeine—Immune system disorder—Temsirolimus—kidney cancer	0.000256	0.00307	CcSEcCtD
Caffeine—CYP2C8—renal system—kidney cancer	0.000254	0.00637	CbGeAlD
Caffeine—CYP3A5—nephron tubule—kidney cancer	0.000252	0.00633	CbGeAlD
Caffeine—Pulmonary oedema—Gemcitabine—kidney cancer	0.000251	0.003	CcSEcCtD
Caffeine—Cardiac disorder—Pazopanib—kidney cancer	0.000248	0.00297	CcSEcCtD
Caffeine—Malnutrition—Temsirolimus—kidney cancer	0.000247	0.00296	CcSEcCtD
Caffeine—CYP2C8—kidney—kidney cancer	0.000245	0.00616	CbGeAlD
Caffeine—Sepsis—Gemcitabine—kidney cancer	0.000245	0.00293	CcSEcCtD
Caffeine—Dry skin—Sorafenib—kidney cancer	0.000243	0.00291	CcSEcCtD
Caffeine—Deafness—Vincristine—kidney cancer	0.000241	0.00288	CcSEcCtD
Caffeine—Blood creatinine increased—Sunitinib—kidney cancer	0.000239	0.00286	CcSEcCtD
Caffeine—Hyperglycaemia—Everolimus—kidney cancer	0.000238	0.00285	CcSEcCtD
Caffeine—CYP1A2—renal system—kidney cancer	0.000237	0.00596	CbGeAlD
Caffeine—Infestation—Everolimus—kidney cancer	0.000235	0.00281	CcSEcCtD
Caffeine—Infestation NOS—Everolimus—kidney cancer	0.000235	0.00281	CcSEcCtD
Caffeine—CYP2E1—nephron tubule—kidney cancer	0.000235	0.0059	CbGeAlD
Caffeine—Gastritis—Sorafenib—kidney cancer	0.000235	0.00281	CcSEcCtD
Caffeine—CYP1A1—renal system—kidney cancer	0.000234	0.00588	CbGeAlD
Caffeine—Dry skin—Sunitinib—kidney cancer	0.000234	0.0028	CcSEcCtD
Caffeine—Malnutrition—Pazopanib—kidney cancer	0.000233	0.00279	CcSEcCtD
Caffeine—Renal failure—Everolimus—kidney cancer	0.000231	0.00277	CcSEcCtD
Caffeine—CYP3A5—renal system—kidney cancer	0.000229	0.00575	CbGeAlD
Caffeine—Deafness—Gemcitabine—kidney cancer	0.000229	0.00274	CcSEcCtD
Caffeine—Infestation—Erlotinib—kidney cancer	0.000227	0.00272	CcSEcCtD
Caffeine—Infestation NOS—Erlotinib—kidney cancer	0.000227	0.00272	CcSEcCtD
Caffeine—CYP1A1—kidney—kidney cancer	0.000226	0.00569	CbGeAlD
Caffeine—Renal failure—Erlotinib—kidney cancer	0.000223	0.00267	CcSEcCtD
Caffeine—CYP3A5—kidney—kidney cancer	0.000221	0.00556	CbGeAlD
Caffeine—CYP3A5—cortex of kidney—kidney cancer	0.000216	0.00542	CbGeAlD
Caffeine—Convulsion—Temsirolimus—kidney cancer	0.000214	0.00256	CcSEcCtD
Caffeine—CYP2E1—renal system—kidney cancer	0.000213	0.00537	CbGeAlD
Caffeine—Hypertension—Temsirolimus—kidney cancer	0.000213	0.00255	CcSEcCtD
Caffeine—Urine output increased—Paclitaxel—kidney cancer	0.000213	0.00255	CcSEcCtD
Caffeine—Haemoglobin—Vinblastine—kidney cancer	0.000213	0.00255	CcSEcCtD
Caffeine—Haemoglobin—Everolimus—kidney cancer	0.000212	0.00254	CcSEcCtD
Caffeine—Haemorrhage—Vinblastine—kidney cancer	0.000212	0.00254	CcSEcCtD
Caffeine—Haemorrhage—Everolimus—kidney cancer	0.000211	0.00253	CcSEcCtD
Caffeine—CYP1A1—cardiac atrium—kidney cancer	0.00021	0.00527	CbGeAlD
Caffeine—CYP2E1—kidney—kidney cancer	0.000206	0.00519	CbGeAlD
Caffeine—Haemoglobin—Erlotinib—kidney cancer	0.000205	0.00245	CcSEcCtD
Caffeine—Sepsis—Paclitaxel—kidney cancer	0.000205	0.00245	CcSEcCtD
Caffeine—Infestation NOS—Sorafenib—kidney cancer	0.000204	0.00244	CcSEcCtD
Caffeine—Infestation—Sorafenib—kidney cancer	0.000204	0.00244	CcSEcCtD
Caffeine—Haemorrhage—Erlotinib—kidney cancer	0.000204	0.00244	CcSEcCtD
Caffeine—Hypertension—Pazopanib—kidney cancer	0.000201	0.00241	CcSEcCtD
Caffeine—CYP2E1—cortex of kidney—kidney cancer	0.000201	0.00505	CbGeAlD
Caffeine—Renal failure—Sorafenib—kidney cancer	0.000201	0.0024	CcSEcCtD
Caffeine—Infection—Temsirolimus—kidney cancer	0.0002	0.0024	CcSEcCtD
Caffeine—Hyperglycaemia—Sunitinib—kidney cancer	0.000199	0.00238	CcSEcCtD
Caffeine—Nervous system disorder—Temsirolimus—kidney cancer	0.000198	0.00237	CcSEcCtD
Caffeine—Infestation—Sunitinib—kidney cancer	0.000196	0.00235	CcSEcCtD
Caffeine—Infestation NOS—Sunitinib—kidney cancer	0.000196	0.00235	CcSEcCtD
Caffeine—Cardiac disorder—Everolimus—kidney cancer	0.000196	0.00234	CcSEcCtD
Caffeine—Skin disorder—Temsirolimus—kidney cancer	0.000196	0.00234	CcSEcCtD
Caffeine—Renal failure—Sunitinib—kidney cancer	0.000193	0.00231	CcSEcCtD
Caffeine—Blood creatinine increased—Gemcitabine—kidney cancer	0.000192	0.00229	CcSEcCtD
Caffeine—Deafness—Paclitaxel—kidney cancer	0.000191	0.00229	CcSEcCtD
Caffeine—Immune system disorder—Everolimus—kidney cancer	0.000191	0.00228	CcSEcCtD
Caffeine—Infection—Pazopanib—kidney cancer	0.000189	0.00226	CcSEcCtD
Caffeine—Injury—Paclitaxel—kidney cancer	0.000186	0.00223	CcSEcCtD
Caffeine—Nervous system disorder—Pazopanib—kidney cancer	0.000186	0.00223	CcSEcCtD
Caffeine—Skin disorder—Pazopanib—kidney cancer	0.000185	0.00221	CcSEcCtD
Caffeine—Haemoglobin—Sorafenib—kidney cancer	0.000184	0.0022	CcSEcCtD
Caffeine—Malnutrition—Everolimus—kidney cancer	0.000184	0.0022	CcSEcCtD
Caffeine—Haemorrhage—Sorafenib—kidney cancer	0.000183	0.00219	CcSEcCtD
Caffeine—Dyspnoea—Temsirolimus—kidney cancer	0.00018	0.00215	CcSEcCtD
Caffeine—Hypercalcaemia—Doxorubicin—kidney cancer	0.00018	0.00215	CcSEcCtD
Caffeine—Malnutrition—Erlotinib—kidney cancer	0.000177	0.00212	CcSEcCtD
Caffeine—Haemoglobin—Sunitinib—kidney cancer	0.000177	0.00212	CcSEcCtD
Caffeine—Haemorrhage—Sunitinib—kidney cancer	0.000176	0.00211	CcSEcCtD
Caffeine—Hypoglycaemia—Paclitaxel—kidney cancer	0.000176	0.0021	CcSEcCtD
Caffeine—Urine output increased—Capecitabine—kidney cancer	0.000175	0.00209	CcSEcCtD
Caffeine—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.000174	0.00208	CcSEcCtD
Caffeine—CYP3A4—renal system—kidney cancer	0.000172	0.00432	CbGeAlD
Caffeine—Cardiac disorder—Sorafenib—kidney cancer	0.00017	0.00204	CcSEcCtD
Caffeine—Dyspnoea—Pazopanib—kidney cancer	0.000169	0.00203	CcSEcCtD
Caffeine—CYP2D6—renal system—kidney cancer	0.000169	0.00425	CbGeAlD
Caffeine—Agitation—Everolimus—kidney cancer	0.000169	0.00202	CcSEcCtD
Caffeine—Sepsis—Capecitabine—kidney cancer	0.000168	0.00201	CcSEcCtD
Caffeine—CYP3A4—kidney—kidney cancer	0.000166	0.00417	CbGeAlD
Caffeine—Immune system disorder—Sorafenib—kidney cancer	0.000166	0.00198	CcSEcCtD
Caffeine—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000164	0.00196	CcSEcCtD
Caffeine—Cardiac disorder—Sunitinib—kidney cancer	0.000164	0.00196	CcSEcCtD
Caffeine—CYP2D6—kidney—kidney cancer	0.000163	0.00411	CbGeAlD
Caffeine—Blood creatinine increased—Paclitaxel—kidney cancer	0.00016	0.00192	CcSEcCtD
Caffeine—Convulsion—Vinblastine—kidney cancer	0.00016	0.00191	CcSEcCtD
Caffeine—Malnutrition—Sorafenib—kidney cancer	0.00016	0.00191	CcSEcCtD
Caffeine—Hyperglycaemia—Gemcitabine—kidney cancer	0.00016	0.00191	CcSEcCtD
Caffeine—Hypertension—Vinblastine—kidney cancer	0.000159	0.00191	CcSEcCtD
Caffeine—Immune system disorder—Sunitinib—kidney cancer	0.000159	0.00191	CcSEcCtD
Caffeine—Convulsion—Everolimus—kidney cancer	0.000159	0.00191	CcSEcCtD
Caffeine—Hypertension—Everolimus—kidney cancer	0.000159	0.0019	CcSEcCtD
Caffeine—Deafness—Capecitabine—kidney cancer	0.000157	0.00188	CcSEcCtD
Caffeine—Dry skin—Paclitaxel—kidney cancer	0.000157	0.00188	CcSEcCtD
Caffeine—Renal failure—Gemcitabine—kidney cancer	0.000155	0.00185	CcSEcCtD
Caffeine—Malnutrition—Sunitinib—kidney cancer	0.000154	0.00184	CcSEcCtD
Caffeine—Infection—Everolimus—kidney cancer	0.000149	0.00178	CcSEcCtD
Caffeine—Hypersensitivity—Temsirolimus—kidney cancer	0.000149	0.00178	CcSEcCtD
Caffeine—Nervous system disorder—Everolimus—kidney cancer	0.000147	0.00176	CcSEcCtD
Caffeine—Tachycardia—Everolimus—kidney cancer	0.000146	0.00175	CcSEcCtD
Caffeine—Skin disorder—Everolimus—kidney cancer	0.000146	0.00174	CcSEcCtD
Caffeine—Infection—Erlotinib—kidney cancer	0.000144	0.00172	CcSEcCtD
Caffeine—Haemoglobin—Gemcitabine—kidney cancer	0.000142	0.0017	CcSEcCtD
Caffeine—Nervous system disorder—Erlotinib—kidney cancer	0.000142	0.0017	CcSEcCtD
Caffeine—Haemorrhage—Gemcitabine—kidney cancer	0.000142	0.00169	CcSEcCtD
Caffeine—Skin disorder—Erlotinib—kidney cancer	0.000141	0.00168	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000141	0.00168	CcSEcCtD
Caffeine—Cardiac disorder—Vincristine—kidney cancer	0.000138	0.00166	CcSEcCtD
Caffeine—Hypertension—Sorafenib—kidney cancer	0.000138	0.00165	CcSEcCtD
Caffeine—Irritability—Capecitabine—kidney cancer	0.000134	0.00161	CcSEcCtD
Caffeine—ABCB1—nephron tubule—kidney cancer	0.000134	0.00336	CbGeAlD
Caffeine—Dyspnoea—Everolimus—kidney cancer	0.000134	0.0016	CcSEcCtD
Caffeine—Hyperglycaemia—Paclitaxel—kidney cancer	0.000134	0.0016	CcSEcCtD
Caffeine—Convulsion—Sunitinib—kidney cancer	0.000133	0.00159	CcSEcCtD
Caffeine—Hypertension—Sunitinib—kidney cancer	0.000133	0.00159	CcSEcCtD
Caffeine—Infestation NOS—Paclitaxel—kidney cancer	0.000132	0.00158	CcSEcCtD
Caffeine—Infestation—Paclitaxel—kidney cancer	0.000132	0.00158	CcSEcCtD
Caffeine—Blood creatinine increased—Capecitabine—kidney cancer	0.000132	0.00158	CcSEcCtD
Caffeine—Cardiac disorder—Gemcitabine—kidney cancer	0.000131	0.00157	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—kidney cancer	0.000131	0.00157	CcSEcCtD
Caffeine—Renal failure—Paclitaxel—kidney cancer	0.00013	0.00155	CcSEcCtD
Caffeine—Gastrointestinal disorder—Everolimus—kidney cancer	0.00013	0.00155	CcSEcCtD
Caffeine—Infection—Sorafenib—kidney cancer	0.000129	0.00155	CcSEcCtD
Caffeine—Dyspnoea—Erlotinib—kidney cancer	0.000129	0.00154	CcSEcCtD
Caffeine—Dry skin—Capecitabine—kidney cancer	0.000129	0.00154	CcSEcCtD
Caffeine—Immune system disorder—Gemcitabine—kidney cancer	0.000128	0.00153	CcSEcCtD
Caffeine—Nervous system disorder—Sorafenib—kidney cancer	0.000128	0.00153	CcSEcCtD
Caffeine—Rash—Temsirolimus—kidney cancer	0.000127	0.00152	CcSEcCtD
Caffeine—Dermatitis—Temsirolimus—kidney cancer	0.000127	0.00152	CcSEcCtD
Caffeine—Skin disorder—Sorafenib—kidney cancer	0.000126	0.00151	CcSEcCtD
Caffeine—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000125	0.0015	CcSEcCtD
Caffeine—Infection—Sunitinib—kidney cancer	0.000124	0.00149	CcSEcCtD
Caffeine—Gastritis—Capecitabine—kidney cancer	0.000124	0.00149	CcSEcCtD
Caffeine—Nervous system disorder—Sunitinib—kidney cancer	0.000123	0.00147	CcSEcCtD
Caffeine—Skin disorder—Sunitinib—kidney cancer	0.000122	0.00146	CcSEcCtD
Caffeine—ABCB1—renal system—kidney cancer	0.000122	0.00306	CbGeAlD
Caffeine—Rash—Pazopanib—kidney cancer	0.00012	0.00143	CcSEcCtD
Caffeine—Dermatitis—Pazopanib—kidney cancer	0.00012	0.00143	CcSEcCtD
Caffeine—Agitation—Vincristine—kidney cancer	0.000119	0.00143	CcSEcCtD
Caffeine—Haemoglobin—Paclitaxel—kidney cancer	0.000119	0.00143	CcSEcCtD
Caffeine—Haemorrhage—Paclitaxel—kidney cancer	0.000118	0.00142	CcSEcCtD
Caffeine—Infection—Dactinomycin—kidney cancer	0.000118	0.00141	CcSEcCtD
Caffeine—ABCB1—kidney—kidney cancer	0.000118	0.00295	CbGeAlD
Caffeine—Dyspnoea—Sorafenib—kidney cancer	0.000116	0.00139	CcSEcCtD
Caffeine—ABCB1—cortex of kidney—kidney cancer	0.000114	0.00288	CbGeAlD
Caffeine—Convulsion—Vincristine—kidney cancer	0.000113	0.00135	CcSEcCtD
Caffeine—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000112	0.00135	CcSEcCtD
Caffeine—Hypertension—Vincristine—kidney cancer	0.000112	0.00134	CcSEcCtD
Caffeine—Dyspnoea—Sunitinib—kidney cancer	0.000112	0.00134	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—kidney cancer	0.000111	0.00133	CcSEcCtD
Caffeine—Hypersensitivity—Vinblastine—kidney cancer	0.000111	0.00133	CcSEcCtD
Caffeine—Hypersensitivity—Everolimus—kidney cancer	0.000111	0.00132	CcSEcCtD
Caffeine—Cardiac disorder—Paclitaxel—kidney cancer	0.00011	0.00132	CcSEcCtD
Caffeine—Hyperglycaemia—Capecitabine—kidney cancer	0.00011	0.00131	CcSEcCtD
Caffeine—ABCB1—gonad—kidney cancer	0.000109	0.00274	CbGeAlD
Caffeine—Infestation NOS—Capecitabine—kidney cancer	0.000108	0.0013	CcSEcCtD
Caffeine—Infestation—Capecitabine—kidney cancer	0.000108	0.0013	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—kidney cancer	0.000108	0.0013	CcSEcCtD
Caffeine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000108	0.00129	CcSEcCtD
Caffeine—Immune system disorder—Paclitaxel—kidney cancer	0.000107	0.00128	CcSEcCtD
Caffeine—Renal failure—Capecitabine—kidney cancer	0.000106	0.00127	CcSEcCtD
Caffeine—Hypertension—Gemcitabine—kidney cancer	0.000106	0.00127	CcSEcCtD
Caffeine—Infection—Vincristine—kidney cancer	0.000105	0.00126	CcSEcCtD
Caffeine—Nervous system disorder—Vincristine—kidney cancer	0.000104	0.00124	CcSEcCtD
Caffeine—Malnutrition—Paclitaxel—kidney cancer	0.000103	0.00123	CcSEcCtD
Caffeine—Nervousness—Paclitaxel—kidney cancer	0.0001	0.0012	CcSEcCtD
Caffeine—Infection—Gemcitabine—kidney cancer	9.99e-05	0.0012	CcSEcCtD
Caffeine—Nervous system disorder—Gemcitabine—kidney cancer	9.86e-05	0.00118	CcSEcCtD
Caffeine—Haemoglobin—Capecitabine—kidney cancer	9.77e-05	0.00117	CcSEcCtD
Caffeine—Skin disorder—Gemcitabine—kidney cancer	9.77e-05	0.00117	CcSEcCtD
Caffeine—Haemorrhage—Capecitabine—kidney cancer	9.72e-05	0.00116	CcSEcCtD
Caffeine—Hypersensitivity—Sorafenib—kidney cancer	9.6e-05	0.00115	CcSEcCtD
Caffeine—Agitation—Paclitaxel—kidney cancer	9.48e-05	0.00113	CcSEcCtD
Caffeine—Rash—Everolimus—kidney cancer	9.46e-05	0.00113	CcSEcCtD
Caffeine—Dermatitis—Everolimus—kidney cancer	9.45e-05	0.00113	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—kidney cancer	9.28e-05	0.00111	CcSEcCtD
Caffeine—Hypersensitivity—Sunitinib—kidney cancer	9.23e-05	0.0011	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vincristine—kidney cancer	9.15e-05	0.00109	CcSEcCtD
Caffeine—Rash—Erlotinib—kidney cancer	9.13e-05	0.00109	CcSEcCtD
Caffeine—Dermatitis—Erlotinib—kidney cancer	9.12e-05	0.00109	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	9.06e-05	0.00108	CcSEcCtD
Caffeine—Cardiac disorder—Capecitabine—kidney cancer	9.02e-05	0.00108	CcSEcCtD
Caffeine—Dyspnoea—Gemcitabine—kidney cancer	8.96e-05	0.00107	CcSEcCtD
Caffeine—Convulsion—Paclitaxel—kidney cancer	8.94e-05	0.00107	CcSEcCtD
Caffeine—Hypertension—Paclitaxel—kidney cancer	8.91e-05	0.00107	CcSEcCtD
Caffeine—Immune system disorder—Capecitabine—kidney cancer	8.78e-05	0.00105	CcSEcCtD
Caffeine—Hypersensitivity—Dactinomycin—kidney cancer	8.74e-05	0.00105	CcSEcCtD
Caffeine—Gastrointestinal disorder—Gemcitabine—kidney cancer	8.68e-05	0.00104	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—kidney cancer	8.49e-05	0.00102	CcSEcCtD
Caffeine—Malnutrition—Capecitabine—kidney cancer	8.47e-05	0.00101	CcSEcCtD
Caffeine—Infection—Paclitaxel—kidney cancer	8.36e-05	0.001	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—kidney cancer	8.31e-05	0.000994	CcSEcCtD
Caffeine—Nervous system disorder—Paclitaxel—kidney cancer	8.26e-05	0.000988	CcSEcCtD
Caffeine—Tachycardia—Paclitaxel—kidney cancer	8.22e-05	0.000983	CcSEcCtD
Caffeine—Rash—Sorafenib—kidney cancer	8.21e-05	0.000982	CcSEcCtD
Caffeine—Dermatitis—Sorafenib—kidney cancer	8.2e-05	0.000982	CcSEcCtD
Caffeine—Skin disorder—Paclitaxel—kidney cancer	8.18e-05	0.000978	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—kidney cancer	8.02e-05	0.000959	CcSEcCtD
Caffeine—Rash—Sunitinib—kidney cancer	7.9e-05	0.000945	CcSEcCtD
Caffeine—Dermatitis—Sunitinib—kidney cancer	7.89e-05	0.000945	CcSEcCtD
Caffeine—Hypersensitivity—Vincristine—kidney cancer	7.81e-05	0.000934	CcSEcCtD
Caffeine—Dyspnoea—Paclitaxel—kidney cancer	7.51e-05	0.000898	CcSEcCtD
Caffeine—Rash—Dactinomycin—kidney cancer	7.48e-05	0.000895	CcSEcCtD
Caffeine—Hypertension—Capecitabine—kidney cancer	7.31e-05	0.000874	CcSEcCtD
Caffeine—Gastrointestinal disorder—Paclitaxel—kidney cancer	7.27e-05	0.00087	CcSEcCtD
Caffeine—Hyperglycaemia—Doxorubicin—kidney cancer	7.06e-05	0.000845	CcSEcCtD
Caffeine—Infestation—Doxorubicin—kidney cancer	6.98e-05	0.000835	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—kidney cancer	6.98e-05	0.000835	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—kidney cancer	6.86e-05	0.000821	CcSEcCtD
Caffeine—Infection—Capecitabine—kidney cancer	6.86e-05	0.000821	CcSEcCtD
Caffeine—Nervous system disorder—Capecitabine—kidney cancer	6.78e-05	0.000811	CcSEcCtD
Caffeine—Tachycardia—Capecitabine—kidney cancer	6.74e-05	0.000807	CcSEcCtD
Caffeine—Skin disorder—Capecitabine—kidney cancer	6.71e-05	0.000803	CcSEcCtD
Caffeine—Rash—Vincristine—kidney cancer	6.68e-05	0.0008	CcSEcCtD
Caffeine—Dermatitis—Vincristine—kidney cancer	6.68e-05	0.000799	CcSEcCtD
Caffeine—Rash—Gemcitabine—kidney cancer	6.34e-05	0.000759	CcSEcCtD
Caffeine—Dermatitis—Gemcitabine—kidney cancer	6.33e-05	0.000758	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—kidney cancer	6.3e-05	0.000754	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—kidney cancer	6.27e-05	0.00075	CcSEcCtD
Caffeine—Hypersensitivity—Paclitaxel—kidney cancer	6.2e-05	0.000742	CcSEcCtD
Caffeine—Dyspnoea—Capecitabine—kidney cancer	6.16e-05	0.000737	CcSEcCtD
Caffeine—Gastrointestinal disorder—Capecitabine—kidney cancer	5.96e-05	0.000714	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—kidney cancer	5.82e-05	0.000696	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—kidney cancer	5.66e-05	0.000677	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—kidney cancer	5.46e-05	0.000653	CcSEcCtD
Caffeine—Rash—Paclitaxel—kidney cancer	5.31e-05	0.000635	CcSEcCtD
Caffeine—Dermatitis—Paclitaxel—kidney cancer	5.3e-05	0.000635	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—kidney cancer	5.3e-05	0.000634	CcSEcCtD
Caffeine—Hypersensitivity—Capecitabine—kidney cancer	5.09e-05	0.000609	CcSEcCtD
Caffeine—Agitation—Doxorubicin—kidney cancer	5.01e-05	0.0006	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—kidney cancer	4.73e-05	0.000566	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—kidney cancer	4.71e-05	0.000564	CcSEcCtD
Caffeine—Infection—Doxorubicin—kidney cancer	4.42e-05	0.000529	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—kidney cancer	4.37e-05	0.000523	CcSEcCtD
Caffeine—Rash—Capecitabine—kidney cancer	4.36e-05	0.000521	CcSEcCtD
Caffeine—Dermatitis—Capecitabine—kidney cancer	4.35e-05	0.000521	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—kidney cancer	4.35e-05	0.00052	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—kidney cancer	4.33e-05	0.000518	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—kidney cancer	3.97e-05	0.000475	CcSEcCtD
Caffeine—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.84e-05	0.00046	CcSEcCtD
Caffeine—Hypersensitivity—Doxorubicin—kidney cancer	3.28e-05	0.000393	CcSEcCtD
Caffeine—Rash—Doxorubicin—kidney cancer	2.81e-05	0.000336	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—kidney cancer	2.81e-05	0.000336	CcSEcCtD
Caffeine—CYP2C9—Metabolism—CRABP1—kidney cancer	1.91e-06	1.85e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.91e-06	1.85e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALAD—kidney cancer	1.9e-06	1.84e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ITPR2—kidney cancer	1.9e-06	1.84e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PTEN—kidney cancer	1.89e-06	1.83e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—BCHE—kidney cancer	1.89e-06	1.83e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—MAPK3—kidney cancer	1.89e-06	1.83e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—SCARB1—kidney cancer	1.88e-06	1.82e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—KRAS—kidney cancer	1.88e-06	1.82e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—MYC—kidney cancer	1.87e-06	1.82e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—POMC—kidney cancer	1.87e-06	1.82e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.87e-06	1.82e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—RAF1—kidney cancer	1.87e-06	1.82e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MAPK1—kidney cancer	1.87e-06	1.81e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—SLC5A5—kidney cancer	1.86e-06	1.81e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—RELA—kidney cancer	1.86e-06	1.81e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS1—kidney cancer	1.86e-06	1.81e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.86e-06	1.8e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—ERBB2—kidney cancer	1.85e-06	1.8e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—BRAF—kidney cancer	1.85e-06	1.79e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CDKN1B—kidney cancer	1.83e-06	1.78e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—MAPK1—kidney cancer	1.83e-06	1.78e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MTOR—kidney cancer	1.83e-06	1.77e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PSMD7—kidney cancer	1.83e-06	1.77e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.81e-06	1.76e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CDKN1B—kidney cancer	1.81e-06	1.76e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—VEGFA—kidney cancer	1.81e-06	1.76e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—SLC2A1—kidney cancer	1.8e-06	1.75e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL2—kidney cancer	1.79e-06	1.74e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—MAPK1—kidney cancer	1.79e-06	1.74e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—VEGFA—kidney cancer	1.79e-06	1.74e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.79e-06	1.73e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL2—kidney cancer	1.77e-06	1.72e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ITPR2—kidney cancer	1.77e-06	1.72e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—KRAS—kidney cancer	1.77e-06	1.71e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCND1—kidney cancer	1.75e-06	1.7e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.75e-06	1.69e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—JUN—kidney cancer	1.75e-06	1.69e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.75e-06	1.69e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.74e-06	1.69e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PGK1—kidney cancer	1.74e-06	1.69e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CTNNB1—kidney cancer	1.73e-06	1.68e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—KRAS—kidney cancer	1.73e-06	1.68e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTT1—kidney cancer	1.73e-06	1.68e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ACHE—kidney cancer	1.73e-06	1.68e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—BCHE—kidney cancer	1.73e-06	1.68e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCND1—kidney cancer	1.73e-06	1.68e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—JUN—kidney cancer	1.72e-06	1.67e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CDKN1B—kidney cancer	1.72e-06	1.66e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—PIK3CA—kidney cancer	1.71e-06	1.66e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MAPK3—kidney cancer	1.71e-06	1.66e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CTNNB1—kidney cancer	1.71e-06	1.66e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.71e-06	1.66e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—LDHB—kidney cancer	1.71e-06	1.65e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MAPK3—kidney cancer	1.7e-06	1.65e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—KRAS—kidney cancer	1.69e-06	1.64e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PIK3CA—kidney cancer	1.69e-06	1.64e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PTEN—kidney cancer	1.69e-06	1.64e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL2—kidney cancer	1.68e-06	1.63e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PTEN—kidney cancer	1.67e-06	1.62e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MYC—kidney cancer	1.67e-06	1.61e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.65e-06	1.6e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MYC—kidney cancer	1.65e-06	1.6e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SCARB1—kidney cancer	1.64e-06	1.59e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCND1—kidney cancer	1.64e-06	1.59e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.63e-06	1.58e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—JUN—kidney cancer	1.63e-06	1.58e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ACHE—kidney cancer	1.63e-06	1.58e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTT1—kidney cancer	1.63e-06	1.58e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CRABP1—kidney cancer	1.63e-06	1.58e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MAPK1—kidney cancer	1.63e-06	1.58e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—PIK3CA—kidney cancer	1.62e-06	1.57e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS1—kidney cancer	1.62e-06	1.57e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CTNNB1—kidney cancer	1.62e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTT1—kidney cancer	1.62e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ACHE—kidney cancer	1.62e-06	1.57e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MAPK1—kidney cancer	1.61e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.6e-06	1.55e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GSTP1—kidney cancer	1.59e-06	1.54e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PSMD7—kidney cancer	1.59e-06	1.54e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GSTP1—kidney cancer	1.59e-06	1.54e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—POMC—kidney cancer	1.58e-06	1.54e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PTEN—kidney cancer	1.58e-06	1.53e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—kidney cancer	1.57e-06	1.52e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—PIK3CA—kidney cancer	1.56e-06	1.51e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—RAF1—kidney cancer	1.55e-06	1.5e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SCARB1—kidney cancer	1.54e-06	1.5e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KRAS—kidney cancer	1.54e-06	1.49e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—RELA—kidney cancer	1.54e-06	1.49e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SCARB1—kidney cancer	1.53e-06	1.48e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—ERBB2—kidney cancer	1.53e-06	1.48e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS1—kidney cancer	1.53e-06	1.48e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—VEGFA—kidney cancer	1.53e-06	1.48e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KRAS—kidney cancer	1.52e-06	1.48e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.52e-06	1.48e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ITPR2—kidney cancer	1.52e-06	1.47e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS1—kidney cancer	1.52e-06	1.47e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MTOR—kidney cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ABCB1—kidney cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—BCHE—kidney cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—VEGFA—kidney cancer	1.51e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ABCB1—kidney cancer	1.5e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GSTP1—kidney cancer	1.5e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PSMD7—kidney cancer	1.5e-06	1.45e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SLC5A5—kidney cancer	1.49e-06	1.44e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PSMD7—kidney cancer	1.49e-06	1.44e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CA9—kidney cancer	1.48e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GSTM1—kidney cancer	1.46e-06	1.42e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GSTM1—kidney cancer	1.46e-06	1.42e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MAPK3—kidney cancer	1.44e-06	1.4e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SLC2A1—kidney cancer	1.44e-06	1.39e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—POMC—kidney cancer	1.43e-06	1.39e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—VEGFA—kidney cancer	1.43e-06	1.38e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MAPK3—kidney cancer	1.43e-06	1.38e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ABCB1—kidney cancer	1.42e-06	1.38e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—BCHE—kidney cancer	1.42e-06	1.38e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CDKN1B—kidney cancer	1.42e-06	1.37e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—PIK3CA—kidney cancer	1.41e-06	1.37e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—BCHE—kidney cancer	1.41e-06	1.37e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.4e-06	1.36e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MYC—kidney cancer	1.4e-06	1.36e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—PIK3CA—kidney cancer	1.4e-06	1.36e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.4e-06	1.35e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.4e-06	1.35e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.39e-06	1.35e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.39e-06	1.35e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MYC—kidney cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL2—kidney cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CYP1A1—kidney cancer	1.39e-06	1.34e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTT1—kidney cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ACHE—kidney cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GSTM1—kidney cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GSTP1—kidney cancer	1.38e-06	1.34e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MAPK1—kidney cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—kidney cancer	1.37e-06	1.33e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MAPK1—kidney cancer	1.36e-06	1.32e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.36e-06	1.31e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—kidney cancer	1.36e-06	1.31e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCND1—kidney cancer	1.35e-06	1.31e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MAPK3—kidney cancer	1.35e-06	1.31e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—JUN—kidney cancer	1.35e-06	1.31e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.34e-06	1.3e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CTNNB1—kidney cancer	1.34e-06	1.3e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—kidney cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SCARB1—kidney cancer	1.31e-06	1.27e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTEN—kidney cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCB1—kidney cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—kidney cancer	1.3e-06	1.26e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS1—kidney cancer	1.29e-06	1.26e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MAPK1—kidney cancer	1.28e-06	1.25e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—kidney cancer	1.28e-06	1.24e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PSMD7—kidney cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GSTM1—kidney cancer	1.27e-06	1.23e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—kidney cancer	1.26e-06	1.23e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CRABP1—kidney cancer	1.26e-06	1.22e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—kidney cancer	1.21e-06	1.18e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—BCHE—kidney cancer	1.2e-06	1.17e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTP1—kidney cancer	1.2e-06	1.16e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP1A1—kidney cancer	1.2e-06	1.16e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PIK3CA—kidney cancer	1.19e-06	1.16e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.19e-06	1.15e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—kidney cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PIK3CA—kidney cancer	1.18e-06	1.14e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ITPR2—kidney cancer	1.17e-06	1.13e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—kidney cancer	1.15e-06	1.12e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.15e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—kidney cancer	1.14e-06	1.1e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—kidney cancer	1.14e-06	1.1e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.14e-06	1.1e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTP1—kidney cancer	1.13e-06	1.1e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTP1—kidney cancer	1.12e-06	1.09e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK3—kidney cancer	1.11e-06	1.08e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTM1—kidney cancer	1.1e-06	1.07e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTEN—kidney cancer	1.1e-06	1.07e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—kidney cancer	1.08e-06	1.05e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—kidney cancer	1.08e-06	1.05e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.08e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—kidney cancer	1.07e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTT1—kidney cancer	1.07e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ACHE—kidney cancer	1.07e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—kidney cancer	1.06e-06	1.03e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK1—kidney cancer	1.06e-06	1.03e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP1A1—kidney cancer	1.05e-06	1.01e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTM1—kidney cancer	1.04e-06	1.01e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—POMC—kidney cancer	1.03e-06	1e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—POMC—kidney cancer	1.03e-06	1e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTM1—kidney cancer	1.03e-06	9.99e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SCARB1—kidney cancer	1.01e-06	9.79e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—kidney cancer	1e-06	9.71e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS1—kidney cancer	9.99e-07	9.69e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTEN—kidney cancer	9.94e-07	9.64e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.86e-07	9.56e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP1A1—kidney cancer	9.85e-07	9.55e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PSMD7—kidney cancer	9.8e-07	9.5e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP1A1—kidney cancer	9.76e-07	9.47e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—POMC—kidney cancer	9.76e-07	9.46e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.72e-07	9.42e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTP1—kidney cancer	9.58e-07	9.29e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—BCHE—kidney cancer	9.29e-07	9.01e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CA—kidney cancer	9.2e-07	8.92e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC5A5—kidney cancer	9.18e-07	8.9e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—kidney cancer	9.07e-07	8.79e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—POMC—kidney cancer	8.94e-07	8.67e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—kidney cancer	8.9e-07	8.63e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.86e-07	8.59e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTM1—kidney cancer	8.8e-07	8.53e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP1A1—kidney cancer	8.34e-07	8.09e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—kidney cancer	8.25e-07	8e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—kidney cancer	8.24e-07	7.99e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.02e-07	7.78e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—POMC—kidney cancer	7.79e-07	7.56e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—kidney cancer	7.78e-07	7.55e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CA—kidney cancer	7.77e-07	7.54e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTP1—kidney cancer	7.39e-07	7.17e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—POMC—kidney cancer	7.34e-07	7.12e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—POMC—kidney cancer	7.28e-07	7.06e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTEN—kidney cancer	7.2e-07	6.98e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTEN—kidney cancer	7.18e-07	6.97e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—kidney cancer	7.13e-07	6.92e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CA—kidney cancer	7.01e-07	6.8e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—kidney cancer	7e-07	6.78e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.85e-07	6.65e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTM1—kidney cancer	6.79e-07	6.59e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTEN—kidney cancer	6.79e-07	6.58e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.44e-07	6.24e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTEN—kidney cancer	6.22e-07	6.03e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—POMC—kidney cancer	6.22e-07	6.03e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—kidney cancer	6.22e-07	6.03e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—kidney cancer	5.86e-07	5.68e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—kidney cancer	5.81e-07	5.63e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTEN—kidney cancer	5.42e-07	5.26e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTEN—kidney cancer	5.11e-07	4.95e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CA—kidney cancer	5.08e-07	4.92e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CA—kidney cancer	5.07e-07	4.91e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTEN—kidney cancer	5.06e-07	4.91e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—kidney cancer	4.96e-07	4.81e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—POMC—kidney cancer	4.8e-07	4.66e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CA—kidney cancer	4.79e-07	4.64e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CA—kidney cancer	4.39e-07	4.26e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTEN—kidney cancer	4.33e-07	4.2e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—kidney cancer	3.83e-07	3.71e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CA—kidney cancer	3.82e-07	3.71e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.6e-07	3.49e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.57e-07	3.46e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTEN—kidney cancer	3.34e-07	3.24e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.05e-07	2.96e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.36e-07	2.28e-06	CbGpPWpGaD
